Holen Sie sich die Stockscreener-App
9.0683
2.15%
-0.2317
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract - TipRanks
Lucid Diagnostics reports Q4 revenue of $1.5M, VA contract - Investing.com
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Finviz
Canaccord reiterates Buy on Lucid Diagnostics stock, $3 target - Investing.com
Lucid Diagnostics (Nasdaq: LUCD) reports 2025 loss, VA contract win - Stock Titan
Insider Sell: Will PAVmed Inc stock hit new highs in YEAR2026 Pullbacks & Low Risk Entry Point Tips - baoquankhu1.vn
Lucid Diagnostics (NASDAQ: LUCD) adds $25M ATM to $175M shelf - Stock Titan
Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PAVmed Q4 2025 earnings preview - MSN
PAVmed (PAVM.US) is scheduled to release its earnings report before the market opens on March 30. - Moomoo
If You Invested $1,000 in Lucid Diagnostics Inc. (LUCD) - Stock Titan
Aug Shorts: Can PAVmed Inc expand into new markets2026 Fundamental Recap & Stock Portfolio Risk Management - baoquankhu1.vn
PAVM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Levels Update: Can PAVmed Inc maintain its current growth rate2026 Major Catalysts & AI Driven Price Predictions - baoquankhu1.vn
PAVmed: Fundamental Analysis and Financial Ratings | 1P50 | US70387R4039 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVM Price History for Pavmed Stock - Barchart
PAVmed Inc.: Fundamental Analysis and Financial Ratings | 1P50 | US70387R5028 - marketscreener.com
Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
Aug Opening: Is PAVmed Inc a stock for growth or value investorsDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
Short Covering: Whats next for PAVmed Inc stockEarnings Overview Summary & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVmed to Hold Q4 and Full Year 2025 Business Update Call on March 30, 2026 - National Today
Price Action: Does PAVmed Inc have pricing power2026 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Analyst Upgrade: Is PAVmed Inc stock a value trap2026 Intraday Action & Safe Entry Trade Reports - baoquankhu1.vn
Stock Recap: Can PAVmed Inc expand into new markets2026 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
PAVM.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Should I Buy - Intellectia AI
Panic Selling: Can PAVmed Inc maintain its current growth rateQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Earnings Risk: Whats next for PAVmed Inc stockJuly 2025 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
PAVM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PAVmed (NASDAQ: PAVM) seeks approval for major share and equity plan changes - Stock Titan
Levels Update: Is PAVmed Inc stock a value trapInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Volatility Watch: Is NVR Inc stock trending bullish2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Earnings Recap: What is PAVmed Incs market position2025 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Ayrton Capital LLC Reduces Stake in Traws Pharma Inc - GuruFocus
Is PAVmed Inc. stock a value trapJuly 2025 Fed Impact & Verified Technical Trade Signals - mfd.ru
Is PAVmed Inc. stock a top performer YTDJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
Can PAVmed Inc. sustain its profitabilityTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
PAVmed Restructures Capital With New Preferred Financing - The Globe and Mail
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PR Newswire
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
PAVmed Regains Compliance with Nasdaq Minimum Bid Price - The Globe and Mail
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
0.00%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):